Helus Pharma (HELP) Stock Price, Quote, News & History

Helus Pharma Inc (HELP) Stock Price, Quote, News & History

HELPNASDAQ

Trade with Public

$5.52

0.275.14%

At close: Mar 9, 5:00 PM EST

$5.62

0.101.81%

After Hours: 7:43 PM EST

Key Statistics

Open

$5.06

$5.52

Volume / Avg.

1.12M / 777.58K

Day Range

$4.93 - $5.57

52 Wk Range

5.24 - 8.97

Market Cap

$280.41M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

4.9

Recent Cybin Inc News

Helus Pharma Stock Tumbles As Anxiety Drug Study Disappoints

Helus Pharma (Cybin) shares fall after Phase 2 anxiety drug results show symptom improvement, but pressure on the stock.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-109.17M

Investing Cash Flow (TTM)

-1.77M

Financing Cash Flow (TTM)

213.09M

Free Cash Flow (TTM)

-110.95M

Capital Expenditure (TTM)

-1.78M

Net Change in Cash (TTM)

102.15M

Analyst Trends and Forecast

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$205.03M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

0.96

Earnings Yield % (TTM)

-81.91%

Earnings Yield % (FWD)

-43.60%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$5.49

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$20.14M

Total Cash

$195.13M

Debt to Equity

Issuance of Debt (TTM)

$24.36M

Repayment of Debt (TTM)

-$20.14M

Key Statistics

Open

$5.06

$5.52

Volume / Avg.

1.12M / 777.58K

Day Range

$4.93 - $5.57

52 Wk Range

5.24 - 8.97

Market Cap

$280.41M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

4.9

About

Sector

Health Care

Industry

Pharmaceuticals

Helus Pharma Inc is a clinical-stage pharmaceutical company developing proprietary novel serotonergic agonists (NSAs), which are synthetic molecules designed to activate serotonin pathways associated with neuroplasticity. These compounds are being in...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Helus Pharma (HELP) stock?

You can purchase shares of Helus Pharma (NASDAQ:HELP) through any online brokerage.

View our list of the best stock brokerages

Who are Helus Pharma (HELP) competitors?

Other companies in Helus Pharma’s space includes: Atea Pharmaceuticals Inc (NASDAQ:AVIR), MediWound Ltd (NASDAQ:MDWD), SNDL Inc (NASDAQ:SNDL), NervGen Pharma Corp (NASDAQ:NGEN) and Aardvark Therapeutics Inc (NASDAQ:AARD).

What is the forecast, or price target, for Helus Pharma (HELP) stock?

Helus Pharma has a consensus price target of $95.00.

What is the current price for Helus Pharma (HELP)?

The stock price for Helus Pharma (NASDAQ: HELP) is $5.62 last updated March 9, 2026 at 7:43 PM EDT.

Does Helus Pharma (HELP) pay a dividend?

There are no upcoming dividends for Helus Pharma.

When is Helus Pharma (NASDAQ:HELP) reporting earnings?

Helus Pharma does not have any upcoming earnings scheduled.

Is Helus Pharma (HELP) going to split?

There is no upcoming split for Helus Pharma.

What sector and industry does Helus Pharma (HELP) operate in?

Helus Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch

Atea Pharmaceuticals Inc

Aardvark Therapeutics Inc

NASDAQ:AARD

$5.98

-1.81%

Rani Therapeutics Holdings Inc

SIGA Technologies Inc

NASDAQ:SIGA

$5.50

-1.79%

Key Statistics

Open

$5.06

$5.52

Volume / Avg.

1.12M / 777.58K

Day Range

$4.93 - $5.57

52 Wk Range

5.24 - 8.97

Market Cap

$280.41M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

4.9

Recent Cybin Inc News

Helus Pharma Stock Tumbles As Anxiety Drug Study Disappoints

Helus Pharma (Cybin) shares fall after Phase 2 anxiety drug results show symptom improvement, but pressure on the stock.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-109.17M

Investing Cash Flow (TTM)

-1.77M

Financing Cash Flow (TTM)

213.09M

Free Cash Flow (TTM)

-110.95M

Capital Expenditure (TTM)

-1.78M

Net Change in Cash (TTM)

102.15M

Analyst Trends and Forecast

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$205.03M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

0.96

Earnings Yield % (TTM)

-81.91%

Earnings Yield % (FWD)

-43.60%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$5.49

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$20.14M

Total Cash

$195.13M

Debt to Equity

Issuance of Debt (TTM)

$24.36M

Repayment of Debt (TTM)

-$20.14M

Key Statistics

Open

$5.06

$5.52

Volume / Avg.

1.12M / 777.58K

Day Range

$4.93 - $5.57

52 Wk Range

5.24 - 8.97

Market Cap

$280.41M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

4.9

About

Sector

Health Care

Industry

Pharmaceuticals

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry